May 28th 2025
These data are intended to support a new drug application to the FDA in the second half of 2025.
May 1st 2025
A recap of the FDA submissions and regulatory decisions in urology from April 2025.
March 12th 2025
The method involves local delivery of the antibiotic gentamicin directly into the bladder tissue.
January 28th 2025
Check out the key regulatory decisions set to happen early this year.
January 14th 2025
In a recent study of the RELIEF stent, 95% of patients showed no VUR following stent placement.
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test
Combination therapy linked to longer OS vs ADT in veterans with mHSPC